Trials / Completed
CompletedNCT03195504
High-flow Nasal Oxygenation in Obese Patients During Apnea
Effectiveness of Apneic Oxygenation Using High-flow Nasal Cannula in Morbidly Obese Patients Undergoing General Anesthesia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- University Health Network, Toronto · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Before going off to sleep patients are given oxygen to saturate blood with oxygen to extend time before a decrease in the level of oxygen in the blood occurs. During this period, obese patients have a faster decrease in the level of oxygen in their blood. This study uses a device called "high-flow nasal cannula" (HFNC), which delivers humidified high-flow oxygen through 2 small plastic tubes placed just inside nostrils. In the intensive care unit settings this device has been used extensively and has become a standard practice. Purpose of this study is to determine whether these high-flow nasal cannula increase the time safely when going to sleep during elective surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | HFNC | High flow nasal oxygen (60 l) under GA |
| DEVICE | CON (control) | Standard oxygen (10-15 l) under GA |
Timeline
- Start date
- 2017-08-10
- Primary completion
- 2018-04-01
- Completion
- 2018-04-01
- First posted
- 2017-06-22
- Last updated
- 2019-04-19
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT03195504. Inclusion in this directory is not an endorsement.